The data shows the year wise distribution of number of Measles cases in children of age 0-5 years in different states of India. Note:-(1)Measles is an acute viral respiratory illness. It is characterized by a prodrome of fever (as high as 105°F) and malaise, cough, coryza, and conjunctivitis -the three pathognomonic enanthema (Koplik spots) followed by a maculopapular rash .

United Kingdom UK: Immunization: Measles: % of Children Aged 12-23 Months data was reported at 92.000 % in 2017. This stayed constant from the previous number of 92.000 % for 2016. United Kingdom UK: Immunization: Measles: % of Children Aged 12-23 Months data is updated yearly, averaging 86.500 % from Dec 1980 (Median) to 2017, with 38 observations. The data reached an all-time high of 93.000 % in 2015 and a record low of 53.000 % in 1980. United Kingdom UK: Immunization: Measles: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United Kingdom – Table UK.World Bank.WDI: Health Statistics. Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

All children for whom the local authority is responsible who received two doses of MMR on or after their first birthday and at any time up to their fifth birthday as a percentage of all children whose fifth birthday falls within the time period.RationaleMMR is the combined vaccine that protects against measles, mumps and rubella. Measles, mumps and rubella are highly infectious, common conditions that can have serious complications, including meningitis, swelling of the brain (encephalitis) and deafness. They can also lead to complications in pregnancy that affect the unborn baby and can lead to miscarriage.Vaccination coverage is the best indicator of the level of protection a population will have against vaccine preventable communicable diseases. Coverage is closely correlated with levels of disease. Monitoring coverage identifies possible drops in immunity before levels of disease rise.The first MMR vaccine is given to children as part of the routine vaccination schedule, usually within a month of their first birthday. They'll then have a booster dose before starting school, which is usually between three and five years of age. Previous evidence shows that highlighting vaccination programmes encourages improvements in uptake levels.May also have relevance for NICE guidance PH21: Reducing differences in the uptake of immunisations (The guidance aims to increase immunisation uptake among those aged under 19 years from groups where uptake is low).Definition of numeratorTotal number of children whose fifth birthday falls within the time period who received two doses of MMR on or after their first birthday and at any time before their fifth birthday.Data for 2013 to 2014 are available at source at LA level. Data prior to 2013 to 2014 were collected at PCT level and converted to LA level using the criteria as described in the notes section below.Definition of denominatorTotal number of children whose fifth birthday falls within the time period.Data from 2013 and 2014 are available at source at LA level. Data prior to 2013 and 2014 were collected at PCT level and converted to LA level using the criteria as described in the notes section below.CaveatsFull GP postcodes are used to aggregate data to ICB. The GP-level coverage data is collected by NHS Digital Strategic Data Collection Service (SDCS) and published by the UK Health Security Agency (UKHSA) COVER team. ICB data is experimental data and should be treated with caution. It is not an official statistic.

ObjectivesPost-measles increased susceptibility to subsequent infections seems particularly relevant in low-resource settings. We tested the hypothesis that measles causes a specifically increased rate of infections in children, also in a high-resource setting.MethodsWe conducted a retrospective cohort study on a large measles outbreak in Berlin, Germany. All children with measles who presented to hospitals in Berlin were included as cases, children with non-infectious and children with non-measles infectious diseases as controls. Repeat visits within 3 years after the outbreak were recorded.ResultsWe included 250 cases, 502 non-infectious, and 498 infectious disease controls. The relative risk for cases for the diagnosis of an infectious disease upon a repeat visit was 1.6 (95% CI 1.4–2.0, p < 0.001) vs. non-infectious and 1.3 (95% CI 1.1–1.6, p = 0.002) vs. infectious disease controls. 33 cases (27%), 35 non-infectious (12%) and 57 (18%) infectious disease controls presented more than three times due to an infectious disease (p = 0.01, and p = 0.02, respectively). This results in a relative risk of more than three repeat visits due to an infection for measles cases of 1.8 (95% CI 1.3–2.4, p = 0.01), and 1.4 (95% CI 1.0–1.9, p = 0.04), respectively.ConclusionOur study demonstrates for the first time in a high-resource setting, that increased post-measles susceptibility to subsequent infections in children is measles-specific—even compared to controls with previous non-measles infections.

As measles-mumps-rubella (MMR) vaccination is established as routine childhood practice in most industrialised countries and varicella vaccination is now being introduced in many countries during the second year of life, a combined measles-mumps-rubella-varicella vaccine was developed for administration convenience and improved compliance to vaccination. To account for situations where children have received a first dose of MMR vaccine without varicella, this study will evaluate the effect of the combined measles-mumps-rubella-varicella vaccine given in place of the second dose of MMR vaccine. A second dose of the monovalent varicella vaccine will be given to all children participating to this trial since there is a current debate on the need of a second dose to induce a full protection against varicella.

The annual pre-kindergarten (pre-K) through 12th grade school immunization survey collects school-level, grade-specific data on vaccine coverage and exemptions. The survey collects vaccination and exemption status data on children who entered the school system on or before a specified date during the fall semester. Individual vaccine information on each student is not collected. This table shows the statewide vaccination exemptions (medical and religious) and percentage vaccinated and compliant for each school-entry mandated vaccine series reported by school year, grade, and school type. Percentage of students vaccinated is the number of students with the required number of doses of a given vaccine divided by the total number of students. Data for each grade includes all schools who reported with that given grade level. School-mandated vaccine series for students enrolled in kindergarten are inactivated polio, DTaP (diphtheria, tetanus, and acellular pertussis), MMR (measles, mumps, and rubella), hepatitis B, varicella and hepatitis A. Additional mandated vaccines for students enrolled in 7th grade include meningococcal conjugate vaccine (MCV) and Tdap (tetanus, diphtheria, and acellular pertussis). Influenza vaccine is a requirement for pre-K students only, who are 24 through 59 months of age. Each child has 1 of 4 possible vaccination statutes: Vaccinated, Exempt (Religious), Exempt (Medical) or Non-compliant. The criteria shown below are used to assess whether a child is considered vaccinated. • Flu = at least 1 dose of annual influenza vaccine (pre-K only). This is a school entry requirement only for pre-K students 24 through 59 months of age. • Polio = at least 3 doses of inactivated polio vaccine, with the last dose on or after their 4th birthday. This is a school entry requirement starting in kindergarten. • DTaP = at least 4 doses of DTaP vaccine, with the last dose on or after their 4th birthday. This is a school entry requirement starting in kindergarten. • MMR = at least 2 doses of MMR vaccine separated by at least 28 days, with the 1st dose on or after their 1st birthday. This is a school entry requirement starting in kindergarten. • HepB = at least 3 doses of hepatitis B vaccine, with the last dose on or after 24 weeks of age. This is a school entry requirement starting in kindergarten. • Varicella = at least 2 doses of varicella vaccine separated by at least 28 days, with the 1st dose on or after their 1st birthday, or a reliable history of chickenpox disease. This is a school entry requirement starting in kindergarten. • HepA = at least 2 doses of hepatitis A vaccine, given a minimum of six calendar months apart, with the 1st dose on or after their 1st birthday. This is a school entry requirement starting in kindergarten. Starting with the 2019-2020 school year the annual survey included data collection on hepatitis A vaccine for 7th grade students. • MCV = at least 1 dose of meningococcal conjugate vaccine. This is a school entry requirement starting in 7th grade. • Tdap = at least 1 dose of Tdap vaccine. This is a school entry requirement starting in 7th grade. • All = Percentage of students with all above vaccine series required for that grade level. Children without a record of vaccination, but with serologic proof of immunity to certain diseases (measles, mumps, rubella, hepatitis B, hepatitis A, and varicella), meet school entry requirements and may be counted as vaccinated. Data Limitations and Considerations: • The school level data shown here are as tabulated and reported by schools and discrepancies may exist. • The Immunization Program identifies outliers and internally inconsistent data points and works with schools to resolve any data quality issues, when possible. • CT DPH cannot verify the accuracy of vaccine data for individual children or whether the documentation necessary to claim an exemption has been submitted. • Data are collected at the beginning of the school year, by which time vac

All children for whom the local authority is responsible who received one dose of MMR on or after their first birthday and at any time up to their second birthday as a percentage of all children whose second birthday falls within the time period.Note on ward level dataThis data is GP practice level data taken from Fingertips and converted to wards using our Fingertips GP to Ward Lookup Matrix for Birmingham and Solihull dataset. This dataset uses the GP census to allocate an approximate percentage of their patients to each ward based on the citizens home address. RationaleMMR is the combined vaccine that protects against measles, mumps and rubella. Measles, mumps and rubella are highly infectious, common conditions that can have serious complications, including meningitis, swelling of the brain (encephalitis) and deafness. They can also lead to complications in pregnancy that affect the unborn baby and can lead to miscarriage.Vaccination coverage is the best indicator of the level of protection a population will have against vaccine preventable communicable diseases. Coverage is closely correlated with levels of disease. Monitoring coverage identifies possible drops in immunity before levels of disease rise.The first MMR vaccine is given to children as part of the routine vaccination schedule, usually within a month of their first birthday. They'll then have a booster dose before starting school, which is usually between three and five years of age. Previous evidence shows that highlighting vaccination programmes encourages improvements in uptake levels.May also have relevance for NICE guidance PH21: Reducing differences in the uptake of immunisations (The guidance aims to increase immunisation uptake among those aged under 19 years from groups where uptake is low).Definition of numeratorTotal number of children whose second birthday falls within the time period who received one dose of MMR on or after their first birthday and at any time before their second birthday.Data for 2013 to 2014 are available at source at LA level. Data prior to 2013 to 2014 were collected at PCT level and converted to LA level using the criteria as described in the notes section below.Definition of denominatorTotal number of children whose second birthday falls within the time period.Data from 2013to 2014 are available at source at LA level. Data prior to 2013 to 2014 were collected at PCT level and converted to LA level using the criteria as described in the notes section below.CaveatsFull GP postcodes are used to aggregate data to ICB. The GP-level coverage data is collected by NHS Digital Strategic Data Collection Service (SDCS) and published by the UK Health Security Agency (UKHSA) COVER team. ICB data is experimental data and should be treated with caution. It is not an official statistic.

IntroductionVaccine-preventable diseases continue to cause morbidity and mortality despite the introduction of childhood immunizations. Recent media reports from Canada and the United States of America (USA) have highlighted a rise in childhood illnesses like measles, which could have been prevented with vaccines. Parents play a pivotal role in ensuring their children receive timely vaccinations. Immunization reminders can help parents who forget or miss vaccination appointments. In the USA, current literature indicates that Black children have lower vaccination rates than other racialized children and vaccine reminders may improve measles vaccine uptake among Black parents. However, there is limited data in Canada on vaccine uptake in children of Black parents, with evidence suggesting vaccine hesitancy among the Black population.ObjectiveThis scoping review aims to map out existing literature on immunization reminder strategies among parents to identify their impact in improving childhood vaccination rates and promoting child health.Inclusion criteriaThe review will include studies conducted in Canada and the United States of America that focus on immunization reminders for parents who have children under six years and published in English between 2015 and 2025.MethodsDatabase and hand-searching of journals and gray literature will be carried out to retrieve pertinent articles. Studies that meet the inclusion criteria will be eligible for selection. The process of selecting eligible studies will then be summarized on a PRISMA-ScR chart. Collated in data-extraction tables will be authorship information, publication date, methods and findings. The findings, key arguments and themes will be analyzed using a thematic analysis and summarized using a narrative summary.ConclusionThis review will contribute to the existing knowledge on parental preferences for vaccine reminder strategies and their usefulness in increasing childhood vaccination rates. The findings will inform and improve public health strategies aimed at boosting vaccine uptake among children.

The dataset contains details on, 1. Percentage of children under age 5 with symptoms of pneumonia (cough and fast or difficult breathing due to a problem in the chest) for whom advice or treatment was sought from a health facility or provider. 2. Percentage of children under age 5 who had diarrhoea in the two weeks preceding the survey and who received oral rehydration salts (ORS packets or pre-packaged ORS fluids). 3. Percentage of children under five years of age with fever for whom advice or treatment was sought from a health facility or provider. 4. Children sleeping under ITNs – Percentage of children under age 5 who slept under an insecticide-treated mosquito net the night prior to the survey. 5. Percentage of Children 12-23 months who received measles vaccination at any time before the survey 6. Percentage of Children 12-23 months who had received all basic vaccinations at any time before the survey

Rank, number of deaths, percentage of deaths, and age-specific mortality rates for the leading causes of death, by age group and sex, 2000 to most recent year.

Number, and percent of, children who were immunised against measles, mumps and rubella by 5 years of age